Condition

Stage IV Mesothelioma

ClinicalTrials.gov condition label

Clinical trials3

Recruiting0

Common interventions7

Lead sponsors shown3

Clinical trials

3 shown

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerNCT04670445 · 2021-01-23

COMPLETED

Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney DysfunctionNCT02567396 · 2016-06-01

WITHDRAWN

18F-FSPG PET/CT for Cancer Patients on TherapyNCT02599194 · 2015-07-01

COMPLETED

Common interventions

18F-FDGDRUG118F-FSPGDRUG1Educational Video and QPL ListOTHER1Laboratory Biomarker AnalysisOTHER1Pharmacological StudyOTHER1TalazoparibDRUG1Usual CareOTHER1

Leading sponsors

Andrei Iagaru1Massachusetts General Hospital1National Cancer Institute (NCI)1

Trial status mix

COMPLETED2

WITHDRAWN1

Phase mix

NA1

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.